Anti-ZCCHC4 antibody [EPR20492],Abcam,AB211325
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human
Application
Flow Cyt (Intra), WB, IP
Platform ID
BAB079827165
Abcam
Contact
Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215
Email:
Product Specifications
Scientific Background
Specifications
NameAnti-ZCCHC4 antibody [EPR20492]
Cat. No.AB211325
HostRabbit
IsotypeIgG
ReactivityHuman
ApplicationFlow Cyt (Intra), WB, IP
ClonalityMonoclonal
Clone NumberEPR20492
Concentration0.952 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Storage-20°C
Regulatory StatusResearch Use Only
Scientific Background
Target data rRNA N6-methyltransferase that specifically methylates the adenine in position 4220 of 28S rRNA (PubMed : 30531910, PubMed : 31328227, PubMed : 31695039, PubMed : 31799605). N6-methylation of adenine(4220) in 28S rRNA is required for translation (PubMed : 30531910, PubMed : 31799605). See full target information rRNA N6-adenosine-methyltransferase ZCCHC4
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
- Products>Primary Antibodies>Recombinant Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.